Delivery Order SPE2DR25D9225-SPE2DR26FFAY4
- Not listed
- The Defense Logistics Agency issued a delivery order valued at $11,134.20 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of YF-VAX 1 dose vials. The delivery order, awarded on November 5, 2025, with an ultimate completion date of November 28, 2025, utilizes firm fixed-price pricing with no set-aside designation. This delivery order falls under DMS Pharmaceutical Group's recently awarded Indefinite Delivery...
- The Defense Logistics Agency awarded a $106,897.92 firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for YF-VAX 1 dose vials. The award was issued on October 22, 2025, with an ultimate completion date of November 13, 2025. This delivery order was issued without a set-aside designation, demonstrating the contractor's competitive capability in unrestricted federal procurement. DMS Pharmaceutical...
- The Defense Logistics Agency awarded a delivery order valued at $1,113.42 to DMS Pharmaceutical Group Inc. for YF-VAX 1 dose vials, with an ultimate completion date of June 3, 2025. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, will perform the delivery at its facility in Park Ridge, IL. This delivery order utilizes firm fixed-price pricing and was issued without a set-aside designation, allowing the contractor to compete...
- The Defense Logistics Agency awarded a $2,783.55 firm fixed-price delivery order to DMS Pharmaceutical Group Inc. for YF-VAX 1 dose vials, with an ultimate completion date of August 12, 2025. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was selected without a set-aside designation. The place of performance is listed as Park Ridge, IL 60068, and the delivery order represents pharmaceutical supply to support federal healthcare...
- The Defense Logistics Agency awarded a firm fixed-price delivery order valued at $2,783.55 to DMS Pharmaceutical Group Inc. for YF-VAX 1 Dose Vials, with an ultimate completion date of September 29, 2025. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was selected without a set-aside designation. The order will be performed at the contractor's Park Ridge facility and represents a specific product delivery under the company's...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order valued at $1,113.42 by the Defense Logistics Agency (DLA) on September 2, 2025, for YF-VAX 1 dose vials. The award is a firm fixed-price delivery order with no set-aside designation, reflecting the company's competitive standing in federal pharmaceutical procurement. Performance is scheduled for completion by September 23, 2025, at the contractor's...
- The Defense Logistics Agency awarded a delivery order valued at $1,113.42 to DMS Pharmaceutical Group Inc. for YF-VAX 1 dose vials, with an ultimate completion date of July 25, 2025. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was selected without a set-aside designation. The contract is structured as a firm fixed-price delivery order, reflecting the established pricing for this specific pharmaceutical product within the...
- The Defense Logistics Agency awarded a delivery order valued at $1,113.42 to DMS Pharmaceutical Group Inc. for YF-VAX 1 dose vials, with an ultimate completion date of September 3, 2025. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was selected under a firm fixed-price contract type with no set-aside designation. The products will be delivered to Park Ridge, Illinois and support the federal pharmaceutical supply chain...
- The Defense Logistics Agency awarded a delivery order valued at $5,567.10 to DMS Pharmaceutical Group Inc. for YF-VAX 1 dose vials, with an ultimate completion date of November 4, 2025. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was selected without a set-aside designation. The delivery order represents a firm fixed-price contract type, with performance to be completed at the awardee's Park Ridge facility. This delivery...
- The Defense Logistics Agency awarded a $2,783.55 delivery order to DMS Pharmaceutical Group Inc. on September 16, 2025, for YF-VAX 1 Dose Vials with an ultimate completion date of October 7, 2025. This firm fixed-price delivery order carries no set-aside designation and is to be performed in Park Ridge, Illinois. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, serves as the prime contractor and has been registered in the System for Award...
- SPE2DR25D9225Indefinite Delivery Contract
- SPE2DR25D9225-SPE2DR26FFAY4Delivery Order
The Defense Logistics Agency awarded a $1,670.28 firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of YF-VAX 1 dose vials. The delivery order, issued on November 12, 2025, with an ultimate completion date of December 4, 2025, was awarded without a set-aside designation, reflecting the contractor's competitive capability in unrestricted federal procurement. This delivery order is issued under DMS Pharmaceutical Group's Indefinite Delivery Contract with the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, a $30.3 billion government-wide acquisition strategy that establishes multiple regional prime vendor contractors to supply pharmaceuticals, biologics, and medical consumables to Department of Defense healthcare facilities worldwide. DMS Pharmaceutical Group has established itself as a critical supplier within the federal pharmaceutical supply chain, with demonstrated performance across numerous delivery orders spanning a wide range of therapeutic categories including oncology treatments, biologics, vaccines, and specialty medications. The company's PPV-G GEN V prime vendor contract, awarded on November 13, 2025, carries a $499,999,999 ceiling value through December 31, 2036, with a 30-month base period and three 30-month option periods, positioning the contractor to continue supplying essential pharmaceutical products to support Department of Defense military healthcare operations globally.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.7k | 11/12/25 |